SCHEMBL2761587

SCHEMBL2761587

[CH2]CC(CC)CCC(CC)CC

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11722745 0.85 TRPM8 (0.31)
SCHEMBL29099326 0.85 ALDH1A1 (0.39) ALDH1A1TDP1CYP3A4TSHR
SCHEMBL43145 0.84
SCHEMBL21815138 0.84
SCHEMBL82508 0.84
SCHEMBL996135 0.83
SCHEMBL17607397 0.83
SCHEMBL38270 0.82
SCHEMBL218909 0.82
SCHEMBL3994228 0.82 ALDH1A1 (0.40) ALDH1A1TDP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111592751-B Polyphenylene ether-containing resin composition 旭化成株式会社 2023-09-29 CN disclosed
CN-112080126-B Polyphenylene ether-containing resin composition 旭化成株式会社 2023-06-27 CN disclosed
EP-4103577-A1 NOVEL MRNA 5'-END CAP ANALOGS, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE Uniwersytet Warszawski (PL) 2022-12-21 EP disclosed
EP-4103578-A1 NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE Uniwersytet Warszawski (PL) 2022-12-21 EP disclosed
WO-2021162567-A1 NOVEL MRNA 5'-END CAP ANALOGS, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE UNIWERSYTET WARSZAWSKI (PL) 2021-08-19 WO disclosed
WO-2021162566-A1 NOVEL MRNA 5'-END CAP ANALOGS MODIFIED WITHIN PHOSPHATE RESIDUES, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE UNIWERSYTET WARSZAWSKI (PL) 2021-08-19 WO disclosed
EP-3820609-A1 <SMALLCAPS/>? ? ?N? ? ? ? ?USE OF-CHELATING RUTHENIUM COMPLEXES IN THE METATHESIS REACTION Apeiron Synthesis S.A. (PL) 2021-05-19 EP disclosed
EP-3356379-B1 PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS APEIRON SYNTHESIS SA (PL) 2021-03-10 EP disclosed
EP-3408276-A1 5'-PHOSPHOROTHIOLATE MRNA 5'-END (CAP) ANALOGS, MRNA COMPRISING THE SAME, METHOD OF OBTAINING AND USES THEREOF Uniwersytet Warszawski (PL) 2018-12-05 EP disclosed
EP-3356379-A1 PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS Apeiron Synthesis S.A. (PL) 2018-08-08 EP disclosed
EP-3294747-A1 RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE Uniwersytet Warszawski (PL) 2018-03-21 EP disclosed
WO-2017130151-A1 5'-PHOSPHOROTHIOLATE MRNA 5'-END (CAP) ANALOGS, MRNA COMPRISING THE SAME, METHOD OF OBTAINING AND USES THEREOF UNIWERSYTET WARSZAWSKI (PL) 2017-08-03 WO disclosed
WO-2016092424-A1 RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE UNIWERSYTET WARSZAWSKI (PL) 2016-06-16 WO disclosed
EP-3019477-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE Novartis AG (CH) 2016-05-18 EP disclosed
WO-2015003223-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE SPINIFEX PHARMACEUTICALS PTY LTD (AU) 2015-01-15 WO disclosed
EP-2718016-A1 NEW COMPLEXES OF RUTHENIUM, METHOD FOR THEIR PREPARATION, AND THEIR APPLICATION IN OLEFIN METATHESIS REACTIONS Umicore AG & Co. KG (DE) 2014-04-16 EP disclosed
WO-2012168183-A1 NEW COMPLEXES OF RUTHENIUM, METHOD FOR THEIR PREPARATION, AND THEIR APPLICATION IN OLEFIN METATHESIS REACTIONS UMICORE AG & CO. KG (DE) 2012-12-13 WO disclosed
CN-102271667-A Agent for treating stenosis of the spinal canal 2011-12-07 CN disclosed
WO-2010141494-A2 SYNTHESIS OF EZETIMIBE CODEXIS, INC. (US) 2010-12-09 WO disclosed